Literature DB >> 24213518

Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas.

Hiroshi Hirano1, Hajime Maeda, Yukiyasu Takeuchi, Yoshiyuki Susaki, Ryoji Kobayashi, Akio Hayashi, Naoko Ose, Yukie Nakazawa, Toshihiko Yamaguchi, Soichiro Yokota, Masahide Mori.   

Abstract

Survivin is expressed in the cytoplasm and/or nucleus of various types of malignant tumor cells. Cytoplasmic survivin functions as an apoptosis inhibitor, while nuclear survivin is indispensable for complete mitosis completion. To investigate the effect of cigarette smoking on the survivin expression in lung adenocarcinomas at the early developmental stage, we examined the expression of nuclear and cytoplasmic survivin in pathological Stage IA lung adenocarcinomas resected from 38 non-smokers and 44 smokers (current smokers and ex-smokers) using an immunohistochemical method. Labeling indices of nuclear survivin in tumors of smokers were significantly greater than those of non-smokers. The labeling index of nuclear survivin was above 3 % in only 1 (2.6 %) of the 38 tumors of the non-smokers, while the labeling indices in 19 (43.2 %) of 44 tumors of the smokers were above 3 % with a significantly greater frequency. There was no significant difference in the labeling index of nuclear survivin between current smokers and ex-smokers. There was no significant difference in the labeling index of cytoplasmic survivin between tumors of the non-smokers and the smokers. The present results show that cigarette smoking is associated with the higher nuclear surviving expression in lung adenocarcinomas at the early stage, suggesting that cigarette smoking affects the nuclear survivin expression in lung adenocarcinomas at the early developmental stage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24213518     DOI: 10.1007/s00795-013-0061-9

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  10 in total

Review 1.  Nuclear or cytoplasmic expression of survivin: what is the significance?

Authors:  Fengzhi Li; Jie Yang; Nithya Ramnath; Milind M Javle; Dongfeng Tan
Journal:  Int J Cancer       Date:  2005-04-20       Impact factor: 7.396

Review 2.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

Review 3.  Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.

Authors:  Roland H Stauber; Wolf Mann; Shirley K Knauer
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

4.  Influence of cigarette smoking on survival and tumor invasiveness in clinical stage IA lung adenocarcinoma.

Authors:  Ryo Maeda; Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  Ann Thorac Surg       Date:  2012-03-14       Impact factor: 4.330

5.  International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

Authors:  Susan S Devesa; Freddie Bray; A Paloma Vizcaino; D Max Parkin
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

6.  Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.

Authors:  Piyali Dasgupta; Rebecca Kinkade; Bharat Joshi; Christina Decook; Eric Haura; Srikumar Chellappan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-06       Impact factor: 11.205

7.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

8.  Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.

Authors:  Eric T Shinohara; Adriana Gonzalez; Pierre P Massion; Heidi Chen; Ming Li; Andrea S Freyer; Sandra J Olson; Jeremiah J Andersen; Yu Shyr; David P Carbone; David H Johnson; Dennis E Hallahan; Bo Lu
Journal:  Cancer       Date:  2005-04-15       Impact factor: 6.860

9.  Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis.

Authors:  S A Khuder
Journal:  Lung Cancer       Date:  2001 Feb-Mar       Impact factor: 5.705

10.  Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure.

Authors:  Quanri Jin; David G Menter; Li Mao; Waun Ki Hong; Ho-Young Lee
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

  10 in total
  3 in total

1.  Survivin expression in lung cancer: Association with smoking, histological types and pathological stages.

Authors:  Hiroshi Hirano; Hajime Maeda; Toshihiko Yamaguchi; Soichiro Yokota; Masahide Mori; Saburo Sakoda
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial.

Authors:  Adrian Levitsky; Malin C Erlandsson; Ronald F van Vollenhoven; Maria I Bokarewa
Journal:  BMC Med       Date:  2015-09-30       Impact factor: 8.775

3.  Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma.

Authors:  Shicheng Li; Xiao Sun; Shuncheng Miao; Jia Liu; Wenjie Jiao
Journal:  Thorac Cancer       Date:  2017-09-26       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.